Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about outcome of board meeting

20 Jul 2017 Evaluate

Alembic Pharmaceuticals has informed that the Board of Directors of the company at its meeting held today has approved the Unaudited Financial Results for the quarter ended on 30th June, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..